JD Supra12d
FDA Issues Five Warning Letters to Makers of Knockoff GLP-1 Drugs
On December 17, 2024, the FDA published five (5) warning letters previously issued to makers of knockoff GLP-1 drugs. Four of ...
JD Supra13d
FDA Targets GLP-1 Providers with Warning Letters
On December 17, the U.S. Food and Drug Administration (FDA) issued Warning Letters to five companies offering various GLP-1 products, including Semaglutide, Tirzepatide, Retatrutide, Cagrilintide, ...